I. Lemieux

J. Després, I. Lemieux, G. Drobinski, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels.

J. Després, A. Tremblay, P. Poirier, 2019, Atherosclerosis.

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M300043-JLR200

J. Després, J. Engert, M. Vohl, 2003, Journal of Lipid Research.

HDL particle size: a marker of the gender difference in the metabolic risk profile.

J. Després, A. Tremblay, D. Prud'homme, 2002, Atherosclerosis.

Atypical antipsychotics and cardiovascular risk in schizophrenic patients.

J. Després, I. Lemieux, N. Alméras, 2001, Journal of clinical psychopharmacology.

Effect of a low-glycaemic index–low-fat–high protein diet on the atherogenic metabolic risk profile of abdominally obese men

J. Turgeon, A. Tremblay, P. Poirier, 2001, British Journal of Nutrition.

Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.

J. Després, A. Tremblay, I. Lemieux, 2003, Metabolism: clinical and experimental.

Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men.

J. Després, D. Gaudet, M. Vohl, 2002, Atherosclerosis.

Triglycerides Affect Coronary Heart Disease Risk? Energy Partitioning in Gluteal-Femoral Fat: Does the Metabolic Fate of

I. Lemieux, 2011 .

Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.

J. Després, A. Tremblay, D. Prud'homme, 2001, Diabetes care.

Gene expression in a rarely studied intraabdominal adipose depot, the round ligament, in severely obese women: A pilot study

D. Joanisse, D. Richard, I. Lemieux, 2016, Adipocyte.

Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients

J. Després, I. Lemieux, H. Salomon, 2003, Annals of medicine.

Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides.

J. Després, Y. Deshaies, A. Tremblay, 2014, Atherosclerosis.

Sex differences in inﬂammatory markers: what is the contribution of visceral adiposity? 1–3

C. Bouchard, J. Després, L. Pérusse, 2009 .

Changes in circulating vitamin D levels with loss of adipose tissue

J. Després, I. Lemieux, J. Bergeron, 2016, Current opinion in clinical nutrition and metabolic care.

CT-derived abdominal adiposity: distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.

J. Després, Shiwei Liu, Jianbo Gao, 2020, Metabolism: clinical and experimental.

Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women.

C. Bouchard, J. Després, L. Pérusse, 2009, The American journal of cardiology.

C. Bouchard, A. Tremblay, S. Lemieux, 1999 .

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid proﬁle of viscerally obese men

J. Després, J. Engert, M. Vohl, 2003 .

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

G. Dagenais, J. Després, I. Lemieux, 2000, Atherosclerosis.

Overweight, Obesity, and CVD Risk: a Focus on Visceral/Ectopic Fat

J. Després, I. Lemieux, É. Larose, 2022, Current Atherosclerosis Reports.

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

Philippe Pibarot, Olivier F Bertrand, Josep Rodés-Cabau, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Abdominal Obesity in Type 2 Diabetes

I. Lemieux, 2008 .

From individual risk factors and the metabolic syndrome to global cardiometabolic risk

J. Després, A. Tremblay, P. Poirier, 2008 .

ABDOMINAL ADIPOSITY AS A CVD RISK FACTOR : SUBCUTANEOUS OR VISCERAL FAT ?

J. Després, I. Lemieux, B. Arsenault, 2008 .

Obesity, Inflammation, and Cardiovascular Risk

I. Lemieux, P. Mathieu, P Mathieu, 2010, Clinical pharmacology and therapeutics.

Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

J. Després, S. Robins, I. Lemieux, 2012, Drugs.

Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study.

J. Després, R. Luben, N. Wareham, 2007, European heart journal.

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men

V. Marzo, I. Matias, S. Petrosino, 2007, International Journal of Obesity.

Interrelationships between changes in anthropometric variables and computed tomography indices of abdominal fat distribution in response to a 1-year physical activity-healthy eating lifestyle modification program in abdominally obese men.

J. Després, A. Tremblay, P. Poirier, 2014, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

V. Marzo, I. Matias, S. Petrosino, 2009, Diabetologia.

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

I. Lemieux, B. Lamarche, J. Després, 1999, Diabetes & metabolism.

Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease.

T. Church, C. Earnest, I. Lemieux, 2007, Nutrition.

Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.

J. Després, P. Poirier, I. Lemieux, 2018, Progress in cardiovascular diseases.

Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.

J. Després, I. Lemieux, J. Bergeron, 2002, Kidney international.

Angiographically-assessed coronary artery disease associates with HDL particle size in women.

J. Després, D. Gaudet, I. Lemieux, 2012, Atherosclerosis.

Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women.

J. Després, D. Gaudet, I. Lemieux, 2012, Metabolism: clinical and experimental.

Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease.

J. Després, D. Gaudet, M. Vohl, 2002, The American journal of cardiology.

Sex differences in inflammatory markers: what is the contribution of visceral adiposity?

C. Bouchard, J. Després, L. Pérusse, 2009, The American journal of clinical nutrition.

Hypertriglyceridemic Waist: A Simple Marker of High‐Risk Atherosclerosis Features Associated With Excess Visceral Adiposity/Ectopic Fat

J. Després, P. Pibarot, A. Marette, 2018, Journal of the American Heart Association.

Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.

J. Després, M. Dumont, D. Prud'homme, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Men With the Atherogenic Dyslipidemia of the Metabolic Syndrome Gemfibrozil Reduces Plasma C-Reactive Protein Levels in Abdominally Obese

J. Després, D. Prud'homme, I. Lemieux, 2003 .

Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis.

J. Després, P. Pibarot, I. Lemieux, 2006, Journal of the American College of Cardiology.

Contribution of CB1 blockade to the management of high-risk abdominal obesity

I. Lemieux, N. Alméras, J. Després, 2006, International Journal of Obesity.

Metabolic Syndrome: Past, Present and Future

J. Després, I. Lemieux, J. Despres, 2020, Nutrients.

ATVB In Focus Metabolic Syndrome and Atherosclerosis

J. Després, P. Pibarot, P. Poirier, 2009 .

Abdominal obesity: the cholesterol of the 21st century?

J. Després, I. Lemieux, B. Arsenault, 2008, The Canadian journal of cardiology.

The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.

J. Després, A. Tremblay, I. Lemieux, 2009, Metabolism: clinical and experimental.

Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?

Paul Poirier, G. Dagenais, J. Després, 2007, The Canadian journal of cardiology.

Metabolic Syndrome Diagnosis: The Sooner the Better.

I. Lemieux, 2018, Metabolic syndrome and related disorders.

Reversing Type 2 Diabetes: The Time for Lifestyle Medicine Has Come!

I. Lemieux, 2020, Nutrients.

Weight gain with age and coronary atherosclerosis: Only the tip of a deadly iceberg.

J. Després, I. Lemieux, J. Despres, 2023, Atherosclerosis.

The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study

N. J. Wareham, Kay-Tee Khaw, J. Després, 2010, Canadian Medical Association Journal.

The Hypertriglyceridemic Waist Concept: Implication for Evaluation and Management of Cardiovascular Disease Risk in Type 2 Diabetes

I. Lemieux, J. Després, 2003 .

Postprandial Variations of Plasma Inflammatory Markers in Abdominally Obese Men

J. Després, A. Tremblay, I. Lemieux, 2006, Obesity.

Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol.

G. Dagenais, J. Després, I. Lemieux, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Waist Circumference is Useless to Assess the Prevalence of Metabolic Abnormalities in Severely Obese Women

V. Drapeau, A. Tremblay, D. Richard, 2007, Obesity surgery.

Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations.

J. Després, A. Tremblay, I. Lemieux, 2009, Metabolism: clinical and experimental.

Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men.

Denis Prud'homme, J. Després, A. Tremblay, 2003, Atherosclerosis.

Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study.

J. Després, N. Wareham, K. Khaw, 2010, Atherosclerosis.

Metabolic Profile in Severely Obese Women is Less Deteriorated than Expected when Compared to Moderately Obese Women

V. Drapeau, A. Tremblay, D. Richard, 2006, Obesity surgery.

Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity

J. Després, A. Tremblay, P. Poirier, 2009, Annals of medicine.

Leisure-time physical activity is more strongly associated with cardiometabolic risk than occupational physical activity: Results from a workplace lifestyle modification program.

J. Després, P. Poirier, I. Lemieux, 2022, Progress in cardiovascular diseases.

Pro-inflammatory Phospholipid Arachidonic Acid/Eicosapentaenoic Acid Ratio of Dysmetabolic Severely Obese Women

A. Galinier, L. Pénicaud, L. Casteilla, 2012, Obesity Surgery.

Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?

M. Dumont, M. Brochu, D. Prud'homme, 2001, Obesity research.

Associations of insulin-like growth factor binding protein-2 (IGFBP-2) with metabolic profile and hepatic fat deposition in asymptomatic men and women.

J. Després, P. Pibarot, P. Poirier, 2023, American journal of physiology. Endocrinology and metabolism.

Abdominal Obesity and the Metabolic Syndrome

J. Després, I. Lemieux, N. Alméras, 2006 .

Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men

A. Tremblay, P. Poirier, J. Nazare, 2015, International Journal of Obesity.

Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity

J. Després, A. Tremblay, P. Poirier, 2019, International Journal of Obesity.

D. Joanisse, C. Mounier, D. Richard, 2022, Journal of Physiology and Biochemistry.

Adiposity, lifestyle and vitamin D levels: the quest for answers

J. Després, I. Lemieux, J. Bergeron, 2020, International Journal of Obesity.

Abdominal obesity and metabolic syndrome

I. Lemieux, J. Despres, 2006, Nature.

ATVB In Focus Metabolic Syndrome and Atherosclerosis

P. Pibarot, P. Poirier, J. Rodés‐Cabau, 2009 .

Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile

D. Joanisse, D. Richard, I. Lemieux, 2015, Journal of physiology and biochemistry.

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

P. Pibarot, P. Poirier, J. Rodés‐Cabau, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Relationships between circulating 25(OH) vitamin D, leptin levels and visceral adipose tissue volume: results from a 1-year lifestyle intervention program in men with visceral obesity

A. Tremblay, P. Poirier, I. Lemieux, 2019, International Journal of Obesity.

Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile

D. Joanisse, I. Lemieux, P. Mauriège, 2015, Journal of Physiology and Biochemistry.

[Risk factors associated with obesity: a metabolic perspective].

I. Lemieux, A. Pascot, J. Després, 2000, Annales d'endocrinologie.